Search Results
Keyword:CA
U.S. Advanced Light Source Upgrade to Enhance Nanoscale Research Capabilities for Quantum Materials
The Advanced Light Source (ALS) at Lawrence Berkeley National Laboratory in the United States is enhancing its quantum materials research capabilities through an upgrade project. As a U.S. Department of Energy Office of Science user facility, ALS has supported researchers worldwide over the past 30+ years in studying quantum materials such as superconductors, topological insulators, and correlated electron materials, leveraging its synchrotron soft X-ray, ultraviolet, and full-spectrum X-ray experimental capabilities. Doctoral students Wei Francis He (left), Kate Matthews (second from right), and Robin Greifke (right) from the University of California, San Diego, are from the Alex Frañó research group at the ALS COSMIC beamline (7.0.1)...
2026-08-27
Canada's Nuclear Energy Strategy Focuses on Project Financing and Risk Sharing
The Canadian federal government recently unveiled a new nuclear energy strategy, explicitly committing to advancing new nuclear power projects nationwide, strengthening domestic supply chains, expanding uranium resources and nuclear fuel supply, and continuing to support nuclear technology innovation in fission and fusion. The strategy also states that nuclear deployment requires more modern financing tools, more efficient regulatory processes, and closer collaboration among governments, Indigenous communities, and industry. The goal of this strategy is to serve Canada's economic, social, and climate objectives through nuclear energy projects, enhancing national energy security while creating jobs and fostering innovation. As the strategic direction becomes clearer, how to translate policy goals into projects that are financeable and ready for construction has become the key question for the next phase.
2026-08-27
Ukraine's Nurecab Nuclear Capacity Building Project Completes First Implementation Cycle
On August 20, 2026, the final seminar of the international project Nurecab (Nuclear Capacity Building in Ukraine through European Cooperation) was held in Kyiv. The project is funded by the European Union through the Euratom Research and Training Programme and is incorporated into the Horizon Europe framework. The seminar was held in a hybrid format, with a total of 76 experts, researchers, educators, and representatives of national institutions participating, of whom 26 attended in person in Kyiv and 50 joined via video link. The meeting showcased the project's implementation results and facilitated discussions on nuclear energy education in Ukraine, the development of nuclear science, and...
2026-08-27
German BESSY II Research Reveals: Cesium Chloride Seed Layer Can Improve Quality of Perovskite-Silicon Tandem Solar Cells
A team from the Helmholtz-Zentrum Berlin (HZB) in Germany used the BESSY II synchrotron radiation facility to conduct nanoscale analysis of perovskite-silicon tandem solar cells fabricated by evaporation methods, and proposed a new approach to improve the quality of perovskite thin films. The study shows that introducing a thin cesium chloride (CsCl) seed layer between the two sub-cells promotes uniform growth of the perovskite layer while reducing undesirable lead iodide deposition at the interface. The research demonstrates that the cesium chloride seed layer improves the growth of the evaporated perovskite layer and reduces the formation of lead iodide. Scanning electron microscopy images show that the perovskite layer grown without a seed layer (left image) consists of extremely fine crystallites...
2026-08-27
Japan's Helical Fusion and Tohoku University Launch Social Communication Research on Fusion Energy
Helical Fusion recently announced that it has launched a joint research project with the Takahashi-Kariwara Laboratory of the Graduate School of Engineering at Tohoku University in August 2026, focusing on ideal communication methods for the social implementation of fusion energy. The project is planned to last approximately one year, with a focus on exploring the communication methods, dialogue mechanisms, and decision-making pathways required for fusion energy to move toward social application. According to the project plan, both parties will examine cases of existing advanced technologies in areas such as social acceptance and risk perception to study communication strategies needed for the stable application of fusion energy in future society. The research also plans to introduce...
2026-08-27
South Korea's Daewoong Pharmaceutical Partners with Promedius to Promote AI Osteoporosis Screening Solution Using Chest X-rays
Daewoong Pharmaceutical announced on August 27 that it has signed a sales, distribution, and joint promotion agreement with Promedius, a medical imaging AI company, to promote Osteo Signal, an AI-based osteoporosis risk screening solution using chest X-rays, in South Korea. This partnership also marks Daewoong Pharmaceutical's expansion from its existing osteoporosis treatment business into the AI-assisted diagnostics field. Under the agreement, Daewoong Pharmaceutical will leverage its business network covering medical institutions across South Korea, along with its sales and marketing capabilities, to bring the solution into more clinical settings. Promedius will provide medical imaging AI technical support to assist in its deployment in real-world medical environments.
2026-08-27
Hyogo Medical University Hospital to Launch Japan's First Elekta Evo Linear Accelerator System Treatments
Elekta K.K. announced on August 27 that its high-precision radiation therapy device, the Elekta Evo linear accelerator system, will be installed for the first time in Japan at Hyogo Medical University Hospital, with the first treatment scheduled to commence on September 24, 2026. This marks the entry of this next-generation radiation therapy system into clinical application in Japan. As the number of cancer patients increases, the demand for personalized and precise treatment in the field of radiation therapy continues to rise. The Elekta Evo is positioned as a next-generation radiation therapy system capable of covering both routine and more complex cancer treatment scenarios. The system is equipped with Iris, an AI-driven high-definition imaging technology, which enables clearer visualization of the positional relationships between organs in the patient's body...
2026-08-27
Canadian Light Source Synchrotron at University of Saskatchewan Receives $3 Million CAD in Upgrade Funding
On August 26, Innovation Saskatchewan announced that it will provide $3 million CAD in funding to the Canadian Light Source synchrotron at the University of Saskatchewan to support the installation of an advanced solid-state amplifier, advancing the facility's upgrade efforts. According to reports, this solid-state amplifier is a key component of the Canadian Light Source's core particle accelerator and will support the operation of its 22 synchrotron radiation beamlines. The upgrade is expected to enhance facility performance, operational reliability, and energy efficiency, further strengthening its capacity for cutting-edge scientific research. The Canadian Light Source is Canada's only synchrotron facility. Synchrotrons use electromagnetic fields and radiofrequency waves to accelerate electrons to near the speed of light, keeping them in a circular orbit; as electrons move, they generate high-brightness, highly focused synchrotron radiation beams, which are directed to different experimental beamlines to help researchers study material structures and properties at the atomic scale.
2026-08-27
Huzhou, Zhejiang Launches Phase I "Drug-Device Combination" Clinical Trial for the Province's First BNCT System
Recently, the Boron Neutron Tumor Treatment Center at Huzhou Hospital Affiliated to Zhejiang University School of Medicine has drawn attention with the introduction of the province's first Boron Neutron Capture Therapy (BNCT) system. Previously, the system had already initiated a Phase I BNCT drug-device combination clinical trial. According to the system developer, Huapeng Neutron Technology (Hangzhou) Co., Ltd., BNCT is a radiotherapy technique combining drugs and devices, with its core lying in the coordinated use of boron-containing drugs and neutron irradiation. After entering the human body, the boron-containing drug can be absorbed by tumor cells; subsequent neutron beam irradiation triggers a localized reaction to achieve targeted radiotherapy against tumor cells. Unlike conventional radiotherapy, which typically employs fractionated irradiation over a longer treatment course, BNCT emphasizes selective targeting of tumor cells, aiming to reduce damage to surrounding healthy tissues and lower radiotherapy-related side effects such as hair loss and immunosuppression.
2026-08-27
Bangladesh Highlights Potential of Nuclear Technology for Maritime Applications at ATLAS Ministerial Meeting
On August 26, local time, Bangladesh's Minister of Science and Technology, Faqrul Mahbub Anam, stated at the 2026 Ministerial Launch of the Licensing of Atomic Technology for Marine Applications (ATLAS) held in Washington, D.C., USA, that Bangladesh is committed to responsible participation in the global nuclear dialogue and believes that emerging nuclear technologies hold significant potential in the field of maritime applications. Anam stated that in the face of challenges such as climate change, energy security, and growing energy demand, the importance of nuclear energy in reducing emissions and ensuring reliable energy supply is rising. Advanced nuclear technologies, including Small Modular Reactors (SMRs), can provide stable low-carbon electricity and support economic growth, poverty reduction...
2026-08-27
IAEA Launches ATLAS Initiative to Advance Nuclear Energy Maritime Applications
The International Atomic Energy Agency (IAEA) launched the Atomic Technology for Maritime Applications Licensing Scheme (ATLAS) on August 26 in Washington, D.C., United States, aiming to support the safe, reliable, and peaceful use of nuclear energy in civilian vessels and floating nuclear power plants. The two-day ATLAS ministerial launch event, hosted by the United States, attracted approximately 600 delegates from over 50 countries, including international organizations, nuclear and maritime industry enterprises, port authorities, and relevant regulatory and policy departments. The IAEA stated that as nuclear-powered ships and floating nuclear power plants gain increasing attention, closer coordination mechanisms between the nuclear and maritime communities are needed. Maritime shipping carries approximately 80% of global trade volume, and maritime trade demand continues to grow at around 2% annually...
2026-08-27
Malaysia Advances Nuclear Energy Workforce Planning Capacity Building
The International Atomic Energy Agency (IAEA) recently held a national workshop on nuclear energy human resource planning in Malaysia to help the country enhance its workforce forecasting and capacity building for existing and future nuclear applications. The workshop was held from 17 to 21 August 2026 over five days, with participants from MyPOWER Corporation, the Malaysian Nuclear Agency, regulatory bodies, national utilities, and academic and training institutions. The five-day workshop was held in Malaysia from 17 to 21 August 2026, with participants including representatives from MyPOWER Corp...
2026-08-27
Russia's SKIF Synchrotron First Scientific User Competition Expected to Launch in Second Half of 2027
The competition to select the first research teams for the Siberian Circular Photon Source (SKIF) synchrotron in Russia is planned for the second half of 2027. Valery Bukhtiyarov, Director of the Boreskov Institute of Catalysis of the Siberian Branch of the Russian Academy of Sciences, stated at the Technoprom-2026 forum held in Novosibirsk that the first open competition will be launched in the second half of 2027. The institute is responsible for commissioning the construction of this large-scale scientific facility. Bukhtiyarov noted that SKIF is scheduled to receive synchrotron radiation and conduct its first experiments in the autumn. Construction of the facility was completed in June 2026, with an opening ceremony held in August 2026. Once operational, SKIF will use synchrotron radiation to help...
2026-08-27
Moffitt Cancer Center in the U.S. Launches $600 Million Radiopharmaceutical Program
Moffitt Cancer Center in Tampa, Florida, recently announced the launch of a new radiopharmaceutical program, planning to accelerate radiopharmaceutical research, development, and clinical translation through a total infrastructure investment of $600 million. The program will be advanced at the Speros campus of Moffitt Cancer Center in Pasco County, Florida. The campus spans 775 acres, and the related investment will support the development of radiopharmaceutical research and development capabilities, including the construction of new radiochemistry laboratories within the Moffitt Discovery and Innovation Center, which opens this fall. The innovation center has a building area of approximately 255,000 square feet. The program funding will also support the planned comprehensive theranostics center...
2026-08-27
Hungary's Paks Nuclear Power Plant Resumes Full-Capacity Operation
Hungary's Paks Nuclear Power Plant has resumed full-capacity operation. Hungarian authorities announced that the plant, which had previously reduced output due to falling water levels in the Danube River, now has all four reactor units and eight turbines operating normally, with electricity generation restored to maximum levels. Located on the banks of the Danube approximately 100 kilometers south of Budapest, the Paks Nuclear Power Plant is Hungary's only nuclear power station. Previously affected by low water levels in the Danube, the plant's water intake conditions for system cooling were constrained, and three units were temporarily impacted with reduced power output. To improve water intake conditions, dike construction was initiated on the riverbed near the plant, with Hungarian experts using thousands of tons of rock and gravel to advance the work, which was completed ahead of schedule.
2026-08-27